Drug Shortage Report for APIDRA
| Report ID | 170358 |
| Drug Identification Number | 02279479 |
| Brand name | APIDRA |
| Common or Proper name | APIDRA CARTRIDGE |
| Company Name | SANOFI-AVENTIS CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | INSULIN GLULISINE |
| Strength(s) | 100UNIT |
| Dosage form(s) | SOLUTION |
| Route of administration | SUBCUTANEOUS SUBCUTANEOUS |
| Packaging size | 5 cartridges |
| ATC code | A10AB |
| ATC description | INSULINS AND ANALOGUES |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | |
| Actual start date | 2022-09-23 |
| Estimated end date | 2022-10-24 |
| Actual end date | 2022-10-11 |
| Shortage status | Resolved |
| Updated date | 2022-10-12 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | email: [email protected] Telephone: 1-800-265-7927 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2022-10-12 | French | Compare |
| v3 | 2022-10-12 | English | Compare |
| v2 | 2022-09-27 | French | Compare |
| v1 | 2022-09-27 | English | Compare |
Showing 1 to 4 of 4